兔抗人IgG H&L预吸附二抗(ab7155)
Key features and details
- Rabbit Anti-Human IgG H&L preadsorbed
- Host species: Rabbit
- Suitable for: WB, IHC-P, IHC-Fr, ICC/IF, IP, Immunodiffusion, Conjugation, ELISA
概述
-
产品名称
兔抗人IgG H&L预吸附二抗
参阅全部 IgG 二抗 -
宿主
Rabbit -
靶标种属
Human -
经测试应用
适用于: WB, IHC-P, IHC-Fr, ICC/IF, IP, Immunodiffusion, Conjugation, ELISAmore details -
最小交叉反应
Mouse more details -
免疫原
Human IgG whole molecule
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
存储溶液
Preservative: 0.01% Sodium azide
Constituents: 0.88% Sodium chloride, 0.42% Potassium phosphate -
Concentration information loading... -
纯度
Affinity purified -
纯化说明
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
克隆
多克隆 -
研究领域
应用
| 应用 | Ab评论 | 说明 |
|---|---|---|
| WB |
1/10000 - 1/50000.
|
|
| IHC-P |
Use at an assay dependent concentration.
|
|
| IHC-Fr |
Use at an assay dependent concentration.
|
|
| ICC/IF |
1/1000 - 1/10000.
|
|
| IP |
Use at an assay dependent concentration.
|
|
| Immunodiffusion |
Use at an assay dependent concentration.
|
|
| Conjugation |
Use at an assay dependent concentration.
|
|
| ELISA |
1/75000 - 1/500000.
|
| 说明 |
|---|
|
WB
1/10000 - 1/50000. |
|
IHC-P
Use at an assay dependent concentration. |
|
IHC-Fr
Use at an assay dependent concentration. |
|
ICC/IF
1/1000 - 1/10000. |
|
IP
Use at an assay dependent concentration. |
|
Immunodiffusion
Use at an assay dependent concentration. |
|
Conjugation
Use at an assay dependent concentration. |
|
ELISA
1/75000 - 1/500000. |
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (2)
ab7155 被引用在 2 文献中.
- Calzavarini S et al. Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus. Blood 135:1969-1982 (2020). PubMed: 32276277
- Yoshimura N et al. Development of a C1q-immobilized (Cim) assay to measure total antibodies to infliximab and its clinical relevance in patients with inflammatory bowel disease. Cytokine 120:54-61 (2019). PubMed: 31003189